Rituximab therapy leads to reduced imprints of receptor revision in immunoglobulin κ and λ light chains.
about
Rituximab therapy leads to reduced imprints of receptor revision in immunoglobulin κ and λ light chains.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Rituximab therapy leads to red ...... globulin κ and λ light chains.
@en
Rituximab therapy leads to red ...... globulin κ and λ light chains.
@nl
type
label
Rituximab therapy leads to red ...... globulin κ and λ light chains.
@en
Rituximab therapy leads to red ...... globulin κ and λ light chains.
@nl
prefLabel
Rituximab therapy leads to red ...... globulin κ and λ light chains.
@en
Rituximab therapy leads to red ...... globulin κ and λ light chains.
@nl
P2093
P356
P1476
Rituximab therapy leads to red ...... globulin κ and λ light chains.
@en
P2093
Arumugam Palanichamy
Khalid Muhammad
Petra Roll
Stefan Kleinert
Thomas Dörner
P304
P356
10.3899/JRHEUM.111513
P407
P577
2012-04-15T00:00:00Z